- Report
- March 2024
- 197 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- April 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- November 2023
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- March 2024
- 247 Pages
Global
From €4012EUR$4,175USD£3,430GBP
- Report
- December 2022
- 56 Pages
Global
From €3363EUR$3,500USD£2,875GBP
- Report
- November 2022
- 150 Pages
Global
From €5285EUR$5,500USD£4,518GBP
- Report
- August 2020
- 140 Pages
North America
From €2018EUR$2,100USD£1,725GBP
€2883EUR$3,000USD£2,464GBP
The Remote Patient Monitoring Artificial Intelligence (RPM AI) market is a subset of the larger Patient Monitoring Equipment (PME) market. RPM AI is a technology that enables healthcare providers to monitor patients remotely, using AI-driven algorithms to detect changes in vital signs and other health indicators. RPM AI systems can be used to detect early signs of disease, monitor chronic conditions, and provide personalized care. RPM AI systems can also be used to provide real-time feedback to patients, helping them to better manage their health.
RPM AI systems are becoming increasingly popular in healthcare settings, as they provide a cost-effective way to monitor patients remotely. RPM AI systems can also be used to improve patient outcomes, as they can detect changes in vital signs and other health indicators before they become clinically significant.
Some companies in the RPM AI market include Philips, Medtronic, IBM, and GE Healthcare. Show Less Read more